Open AccessLow Prevalence of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates among Connecticut Veterans
Author(s) -
Susan L. Fink,
Richard A. Martinello,
Sheldon Campbell,
Thomas S. Murray
Publication year - 2012
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.05024-11
Subject(s) - vancomycin , staphylococcus aureus , microbiology and biotechnology , medicine , micrococcaceae , antibacterial agent , antibiotics , staphylococcal infections , biology , bacteria , genetics
The Etest glycopeptide resistance detection identified two potential heterogeneous vancomycin-intermediateStaphylococcus aureus (hVISA) isolates from a screen of 288 methicillin-resistantStaphylococcus aureus (MRSA) isolates from patients at a Connecticut Veterans Hospital. However, the two isolates did not meet the criteria for hVISA by the population analysis profile-area under the curve analysis, arguing against routine screening for hVISA in this low prevalence population.